On February 9, 2019 Calithera Biosciences, Inc. (Nasdaq:CALA), a clinical stage biotechnology company focused on the development of novel cancer therapeutics, reported that Susan M. Molineaux, Ph.D, the company’s Founder, President and Chief Executive Officer, will participate in a fireside chat at the Leerink Partners Global Healthcare Conference at 10:00 a.m. ET on Thursday, February 15, 2018 in New York City (Press release, Calithera Biosciences, FEB 9, 2018, View Source [SID1234535246]). The presentation will be webcast live and available for replay for up to 30 days at www.calithera.com in the Investor Relations section

Schedule your 30 min Free 1stOncology Demo!
Discover why more than 1,500 members use 1stOncology™ to excel in:

Early/Late Stage Pipeline Development - Target Scouting - Clinical Biomarkers - Indication Selection & Expansion - BD&L Contacts - Conference Reports - Combinatorial Drug Settings - Companion Diagnostics - Drug Repositioning - First-in-class Analysis - Competitive Analysis - Deals & Licensing

                  Schedule Your 30 min Free Demo!